SvilaasTVlaarPJvan der HorstIC, et al.Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557-67.
2.
VlaarPJSvilaasTvan der HorstIC, et al.Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371:1915-20.
3.
FrobertOLagerqvistBOlivecronaGK, et al.Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587-97.
4.
JollySSCairnsJAYusufS, et al.Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372:1389-98.
5.
JollySSJamesSDzavikV, et al.Thrombus aspiration in ST-Segment-Elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration. Circulation. 2017;135:143-52.
6.
ManolisAS. Is Atherothromboaspiration a possible solution for the prevention of no-reflow phenomenon in acute coronary syndromes? Single centre experience and review of the literature. Curr Vasc Pharmacol. 2019;17:164-79.
7.
YildizBSCetinNGunduzRBilgeAOzgurSOrmanMN. Effect of coronary thrombus aspiration in Non ST elevation acute coronary syndrome patients on three-year survival- does it add any benefit?Angiology. 2022;73:565-78.
8.
HillaniAPotterBJ. Intracoronary thrombus and no-reflow: one size to fit all?Can J Cardiol. 2021;37:202-5.
9.
BrenerSJMaeharaADizonJM, et al.Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. JACC Cardiovasc Interv. 2013;6:718-24.
10.
SharmaVJollySSHamidT, et al.Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: insights from the TOTAL trial. Eur Heart J. 2016;37:1891-8.
11.
TashtishNChamiTDongT, et al.Routine Use of the “Penumbra” thrombectomy device in myocardial infarction: a real-world experience-ROPUST study. J Interv Cardiol. 2022;2022:5692964.
12.
HuangDMaYWuH, et al.Impact of intracoronary reteplase during primary percutaneous coronary intervention on infarct size in large anterior myocardial infarction: rationale and design of the RECOVER II trial. Cardiovasc Diagn Ther. 2022;12:352-9.
13.
ShenJLiuGWuG, et al.Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarction. Eur J Clin Pharmacol. 2022;78(9):1391-98.
14.
AlkhalilMKuzemczakMZhaoR, et al.Prognostic role of residual thrombus burden following thrombectomy: insights from the TOTAL trial. Circ Cardiovasc Interv. 2022;15:e011336.
15.
KaddouraRMohamed IbrahimMIAl-BadriyehDOmarAAl-KindiFArabiAR. Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials. PLoS One. 2022;17:e0263270.
16.
HamzaMElgendyIY. Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial. Rev Esp Cardiol. 2022;75:727-733.
